rnai
activ
crosskingdom
phenomenon
activ
organ
rang
fungi
human
introduct
dsrna
lead
silenc
correspond
match
gene
prior
first
descript
phenomenon
nematod
decad
ago
gene
silenc
describ
plant
fungi
term
posttranscript
gene
silenc
ptg
quell
respect
phenomenon
later
found
act
similarli
rnai
one
main
characterist
rnai
activ
process
dsrna
molecul
small
dsrna
fragment
design
small
interf
rna
sirna
done
dicer
enzym
belong
rnase
iii
famili
dicer
enzym
multidomain
protein
kda
size
possess
rna
helicas
domain
paz
domain
bind
nucleic
acid
prefer
rna
catalyt
domain
doublestrandrnabind
domain
dsrbd
nucleas
activ
enzym
recogn
end
molecul
excis
dsrna
fragment
one
end
form
sirna
molecul
phosphat
end
overhang
dinucleotid
interestingli
e
coli
rnase
iii
use
perform
dsrna
cleavag
fulli
activ
sirna
substrat
use
sirna
pool
gene
silenc
consequ
dsrna
molecul
unwind
atpdepend
process
one
strand
incorpor
rna
interfer
silenc
complex
risc
complex
guid
singlestrand
sirna
complementari
target
rna
cleav
result
gene
silenc
fig
main
protein
constitut
risc
complex
argonaut
character
presenc
two
domain
one
paz
also
found
dicer
paz
domain
dicer
protein
interact
end
sirna
therebi
form
threecompon
connect
threecompon
interact
mediat
paz
domain
probabl
respons
transfer
newli
form
sirna
risc
second
domain
character
piwi
domain
structur
similar
rnashi
rnasehii
domain
furthermor
bioinformat
approach
reveal
piwi
domain
drosophila
melanogast
relat
endonucleas
v
protein
famili
find
indic
exhibit
complet
set
risc
featur
fig
induct
interferon
respons
dsrna
activ
dsrnaidepend
protein
kinas
particular
pkr
render
rnai
ineffect
gene
silenc
interferonproduc
organ
pioneer
work
elbashir
et
al
breakthrough
held
show
first
time
introduct
sirna
cell
induc
gene
silenc
rnai
mechan
public
follow
outburst
report
studi
demonstr
sirna
silenc
larg
number
gene
cell
vertebr
origin
well
virus
sirna
introduc
cell
either
lipofect
part
express
vector
sirna
gene
control
pol
iii
type
promot
hi
form
posit
sirna
strand
proce
base
neg
sirna
strand
follow
serv
transcript
termin
upon
transcript
transcrib
rna
form
stem
loop
structur
process
dicer
produc
fulli
activ
sirna
fig
base
techniqu
sirna
cassett
apli
viral
vector
adeno
associ
retro
virus
review
summar
avail
data
concern
silenc
viral
replic
direct
interfer
viral
gene
well
silenc
cell
function
involv
viru
replic
picorna
virus
nonenvelop
virus
genom
posit
orient
singlestrand
ss
rna
kb
size
bestknown
viru
famili
polio
viru
caus
poliomyel
still
threat
sever
develop
countri
genom
carri
one
open
read
frame
newli
synthes
polyprotein
cleav
autoproteolyt
process
three
cleav
matur
protein
polypeptid
carri
viral
structur
gene
vp
well
la
proteas
wherea
carri
nonstructur
protein
nsp
viru
one
first
report
potenti
sirna
inhibit
anim
viru
replic
gitlin
et
concern
polio
viru
show
viral
inhibit
two
sirna
test
one
target
viral
protein
gene
second
design
cleav
polymeras
gene
nonstructur
protein
case
almost
complet
inhibit
indic
reduct
viru
titer
signific
decreas
viral
rna
protein
treat
cell
one
cardin
issu
use
rnai
therapeut
approach
virus
escap
result
select
pressur
target
sequenc
mutat
suppress
silenc
activ
sirna
molecul
phenomenon
exactli
record
inhibit
polioviru
examin
long
period
time
even
singl
mutat
result
g
u
mismatch
suppress
viral
inhibit
sirna
moreov
experi
sever
escap
virus
isol
exhibit
differ
mutat
sirna
site
overcom
advers
effect
gitlin
et
al
use
mixtur
sirna
molecul
origin
dicertr
segment
dsrna
correspond
viral
sequenc
sinc
mixtur
contain
sirna
molecul
aim
numer
site
viral
genom
small
number
mutat
affect
overal
inhibitori
effect
would
permit
emerg
revertant
experi
perform
escap
virus
could
detect
least
durat
experi
similar
ident
approach
taken
kahana
et
al
order
inhibit
replic
footandmouth
diseas
viru
fmdv
fmdv
also
belong
aphtopicornaviru
genu
picornavirida
famili
infect
clovenhoof
anim
import
farm
anim
pathogen
order
silenc
viru
complet
kahana
et
al
search
among
viral
entri
genbank
databas
viral
sequenc
show
homolog
fmd
viru
least
segment
analysi
reveal
three
sequenc
becam
base
synthes
three
sirna
molecul
correspond
three
site
cell
transfect
individu
sirna
molecul
prior
infect
inhibit
rate
simultan
transfect
three
complet
inhibit
viru
replic
obtain
observ
use
realtim
rtquantit
q
pcr
viru
titer
could
argu
approach
would
also
lead
inhibit
seven
differ
viral
serotyp
use
sirna
molecul
achiev
sinc
target
sequenc
present
fmdv
regardless
origin
moreov
conserv
sequenc
throughout
viral
evolut
indic
strong
select
pressur
mutat
preserv
sequenc
chang
cours
viru
evolut
select
pressur
would
maintain
sirna
target
sequenc
unchang
ensur
proper
activ
describ
sirna
virus
target
sirna
sequenc
found
throughout
genom
case
fmdv
sirna
target
gene
least
conserv
gene
among
fmdv
viru
gene
also
use
success
inhibit
viru
replic
cell
also
reduc
viru
titer
infect
suckl
mice
receiv
subcutan
inject
sirnaexpress
vector
hepat
c
envelop
viru
sole
member
genu
hepacviru
flavivirida
famili
viral
genom
posit
orient
singlestrand
rna
kb
length
carri
singl
open
read
frame
translat
polyprotein
cleav
host
well
viral
proteinas
produc
matur
protein
n
terminu
genom
encod
core
structur
protein
remaind
genom
encod
nonstructur
one
untransl
region
utr
carri
transcript
initi
site
transcript
positivestrand
rna
intern
ribosom
entri
site
ire
initi
viral
protein
synthesi
infect
hpc
viru
one
major
viral
diseas
human
worlwid
estim
peopl
hpc
seroposit
obvious
one
first
virus
check
possibl
inhibit
mean
rnai
one
main
approach
design
sirna
target
identif
highli
conserv
region
among
isol
specif
viru
describ
fmdv
hpcv
conserv
region
utr
particularli
ire
region
yokota
cowork
use
design
strategi
design
sirna
molecul
target
variou
region
utr
ire
sequenc
test
six
sirna
gene
silenc
level
uniform
sirna
correspond
region
upstream
aug
start
codon
could
provid
high
inhibit
rate
gene
equal
effect
sirna
molecul
opposit
effect
ie
increas
replic
rate
contrari
observ
takigawa
et
al
report
sirna
target
region
unabl
inhibit
replic
viru
hand
author
found
sirna
target
region
less
conserv
utr
also
highli
effect
inhibit
viru
activ
achiev
inhibit
influenza
viru
member
orthomyxovirida
respons
acut
upper
respiratori
diseas
viral
genom
compos
eight
neg
orient
ssrna
segment
influenza
viru
infect
sever
health
problem
worldwid
caus
million
case
diseas
estim
death
year
resort
recombin
event
involv
avian
influenza
viru
genom
could
produc
new
highli
virul
viru
abl
cross
speci
barrier
bird
human
high
mortal
rate
among
infect
individu
eight
genom
segment
sirna
molecul
target
differ
genom
test
sever
sirna
molecul
target
pa
np
segment
found
profound
effect
viru
replic
mbdk
cell
result
impli
sirna
target
gene
would
less
effect
shown
hui
et
al
shown
sirna
target
viru
matrix
mi
gene
effect
inhibit
viru
replic
cell
could
shown
sirna
effect
inhibit
influenza
replic
vitro
approach
led
inhibit
viru
replic
mice
vivo
sirna
molecul
prepar
complex
oligofectamin
polyethylenimin
pei
deliv
intraven
intranas
mark
reduct
viru
replic
sirna
target
np
pa
gene
simultan
broad
rang
reduct
replic
viral
serotyp
import
result
inhibitori
effect
sirna
highli
pathogen
avian
influenza
virus
south
east
asia
capabl
infect
human
approach
succeed
vivo
doublestrand
sirna
introduc
mice
sirna
also
highli
activ
deliv
gene
pol
iii
type
promot
lentiviru
vector
sarscov
novel
highli
danger
coronaviru
identifi
origin
avian
viru
cross
speci
barrier
infect
human
character
high
mortal
rate
among
infect
peopl
phenomenon
caus
sever
health
problem
worldwid
especi
southeast
asia
canada
case
human
infect
found
genom
like
coronavirus
ssrna
posit
orient
kb
length
case
describ
virus
sever
sirna
target
variou
locat
viral
genom
viral
replicas
spike
gene
design
abil
silenc
express
gene
also
inhibit
viral
replic
demonstr
hiv
present
major
health
problem
reach
pandem
proport
especi
develop
countri
one
first
virus
test
abil
rnai
approach
inhibit
sinc
sever
excel
review
subject
publish
one
aspect
viru
inhibit
discuss
present
review
name
variou
mean
use
overcom
phenomenon
viru
escap
result
high
rate
mutat
viru
prevent
futur
use
approach
therapeut
purpos
exceedingli
high
mutat
rate
viral
genom
sirna
target
sequenc
also
mutat
high
rate
impair
longterm
effect
sirna
eventu
lead
emerg
escap
virus
overcom
effect
sirna
viru
replic
sever
phenomenon
indic
fact
sequenc
sirna
target
genom
viru
determin
found
mutat
target
sequenc
could
break
sirna
activ
mutat
adjac
actual
target
sequenc
could
also
stop
sirna
activ
sever
attempt
made
address
issu
one
approach
involv
scan
viru
sequenc
order
find
region
conserv
sequenc
locat
across
viral
genom
rais
sirna
gene
correspond
region
mean
approach
sirna
molecul
correspond
gag
pol
int
vpu
sequenc
shown
inhibit
three
differ
hiv
strain
effect
although
longterm
protect
evalu
seem
approach
potenti
find
viral
sequenc
mutat
would
result
product
attenu
nonviabl
virus
moreov
use
sever
sirna
gene
simultan
would
excel
chanc
protect
appear
escap
virus
overcom
select
pressur
sirna
activ
predict
model
develop
leonard
shaffer
stochast
comput
model
test
differ
approach
overcom
appear
mutat
escap
sirna
predict
use
sever
sirna
target
differ
locat
would
dramat
increas
sirna
efficaci
model
also
predict
small
increas
number
sirna
target
would
drastic
increas
effici
sirna
approach
reduc
elimin
appear
escap
virus
studi
also
highlight
import
transform
effici
sirna
gene
molecul
ensur
infect
cell
contain
sirna
molecul
hivproduc
cell
carri
inhibitori
molecul
viru
replic
would
continu
cell
increas
likelihood
appear
escap
virus
anoth
approach
inhibit
hiv
replic
involv
direct
sirna
cell
function
indispens
viru
life
cycl
function
perform
cell
viral
receptor
cell
membran
sirna
target
gene
test
found
hiv
replic
could
suppress
repress
viru
entri
confer
resist
infect
interest
approach
taken
studi
involv
use
bispecif
short
hairpin
sh
rna
molecul
target
two
differ
gene
even
though
silenc
suppress
viru
infect
effect
silenc
would
practic
approach
import
protein
immun
system
gene
would
realist
target
major
coreceptor
macrophag
molecul
dispens
sinc
homozygot
individu
protect
viral
infect
without
abnorm
phenotyp
transfect
specif
sirna
macrophag
follow
viru
infect
reduc
viru
replic
almost
complet
primari
human
microglia
day
post
challeng
inhibit
complet
anoth
approach
complet
inhibit
replic
involv
target
two
site
one
entri
way
gene
second
viral
gene
gene
approach
test
use
sirna
viral
simultan
viru
reproduct
complet
elimin
even
test
appli
day
post
challeng
experi
demonstr
inhibit
conserv
viru
function
togeth
cellular
function
import
viru
life
cycl
sustain
inhibitori
effect
replic
pursu
therapeut
purpos
differ
cell
function
function
test
poli
adpribos
polymeras
nuclear
enzym
catalys
transfer
nad
adpribos
moieti
nuclear
protein
includ
need
activ
target
gene
human
immunodefici
viru
type
longtermin
repeat
ltr
lack
prevent
integr
genom
shown
knockout
cell
make
excel
choic
effect
suppress
replic
predict
sirna
target
gene
effici
suppress
replic
human
hela
cell
line
furthermor
silenc
gene
effect
restrict
viru
integr
genom
hepat
b
hb
major
health
problem
mani
countri
estim
million
peopl
worldwid
carrier
viru
infect
caus
liver
cirrhosi
hepatocellular
carcinoma
respons
million
fatal
annual
viru
genom
partial
doublestrand
small
dna
relaxedcircular
dna
structur
fig
one
main
uniqu
featur
genom
dna
replic
revers
transcript
step
contrast
rna
virus
sirna
also
abl
cleav
genom
dna
virus
inhibit
due
silenc
viral
function
viral
mrrna
cleavag
similarli
activ
cellular
function
describ
regard
virus
sirna
target
specif
site
inhibit
viru
replic
sever
transit
express
sirna
target
sequenc
locat
throughout
viral
genom
test
found
elicit
largescal
inhibit
viru
replic
mention
earlier
one
main
concern
regard
sirna
deliveri
transfect
effici
sinc
sirna
molecul
either
form
dsrna
express
vector
must
enter
infect
cell
order
stop
viru
replic
complet
one
way
ensur
use
stabl
transform
cell
guarante
presenc
sirna
everi
infect
cell
report
chen
et
al
test
differ
sirna
gene
aim
viral
gene
abl
show
viral
rna
level
could
reduc
one
import
aspect
use
sirna
activ
dna
virus
need
show
inhibit
viral
dna
replic
amount
viral
dna
quantifi
almost
viral
dna
could
detect
demonstr
inhibit
genom
replic
similarli
inhibit
genom
replic
rna
virus
sinc
result
vitro
assay
indic
practic
applic
potenti
approach
must
test
vivo
perform
giladi
et
al
uprichard
et
al
giladi
et
al
show
coinject
plasmid
carri
hbv
genom
plasmid
carri
sirna
gene
correspond
sequenc
small
hbv
surfac
antigen
hbsag
mark
decreas
hbsag
hbeag
decreas
three
viral
mrna
far
dramat
effect
viral
dna
replic
day
inject
viral
dna
remain
undetect
level
uprichard
et
al
use
somewhat
differ
system
achiev
similar
result
infect
hbv
transgen
mice
adenoviru
vector
carri
sirna
gene
target
overlap
sequenc
abl
reduc
level
hbsag
hbeag
serum
infect
mice
silenc
viral
rna
maintain
atleast
day
post
infect
confirm
effect
approach
day
post
infect
dna
replic
remain
undetect
level
remain
end
experi
day
herp
virus
one
largest
group
dna
virus
infect
vertebr
genom
dsdna
rang
kbp
length
viru
replic
nucleu
littl
work
publish
use
sirna
inhibit
herp
virus
bhuyar
et
al
demonstr
abil
sirna
silenc
ge
glycoprotein
transmembran
glycoprotein
involv
celltocel
movement
summari
rnai
employ
virolog
offer
first
time
possibl
control
viral
diseas
approach
similar
potenti
impact
human
anim
plant
health
antibiot
last
centuri
